Phenotypic Analysis of T Lymphocytes Isolated from Non-Small-Cell Lung Cancer

International Archives of Allergy and Immunology

Volumn 114, Issue 1, 1997, Pages 38-45

  Riemann, Dagmar ^a   Wenzel, Katrin ^a   Schulz, Torsten ^b   Hofmann, Stefan ^b   Neef, Heinz ^b   Lautenschläger, Christine ^c   Langner, Jürgen ^a  

^a Institute of Medical Immunology   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c Medical Faculty   (Germany)

Author keywords

Flow cytometry; Immunophenotype; Lymphocytes; Non small cell lung cancer; Prognostic factors; Tumor infiltrating

Indexed keywords

ANTINEOPLASTIC AGENT; MICROSOMAL AMINOPEPTIDASE;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CYTOFLUOROMETRY; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0030876902     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237640     Document Type: Article

References (28)

1. Wei YQ, Hang ZB: In situ observation of lym-phocyte-tunior cell interaction in human lung carcinoma, Immunol Invest 1989; 18:1095-1105.
2. Lee T-K, Homer RD, Silverman JF, Chen Y-H, Jenny C, Scarantino CW: Morphometric and morphologic evaluations in stage III non-small cell lung cancers, Cancer 1988:63:309-316.
3. Riemann D, Goehring B, Langncr J: Expression of the aminopetidase N/CDI3 in tumour-infiltrating lymphocytes from human renal cell carcinoma, Immunol Lett 1994;42:19-23.
4. Zocchi MR, Poggi A, Crosti F, Tongiani S, Ru-garli C: Signalling in human tumour infiltrating lymphocytes: The CD28 molecule is functional and is physically associated with the CD45RO molecule, Eur J Cancer 1992;28:749-754.
5. Loannides CO, Whiteside TL: Tcell recognition of human tumors, Implication for molecular immunotherapy of cancer, Clin Immunol Immu-nopharmacol 1993:66:91-106.
6. Yoshino I, Yano T, Murata M, Ishida T, Sugi- 10 machi K, Kimura G, Nomoto K: Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor-cell derived factors, Cancer Res 1992:52:775-781.
7. Huang M, Wang J, Lee P, Sharma S, Mao JT, Meissner H, Uyentura K, Modlin R, Wollman J, Dubinett SM: Human non-small cell lung cancer express a type 2 cytokine pattern, Cancer Res 1995;55:3847-3853.
8. Chelcn CJ, Fang Y, Freeman GJ, Secrist H, Marshall JD, Hwang PT, Frankel LR, DeKruyff RH, Umetsu DT: I luman alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface mole- 13 cules, J Clin Invest 1995:95:1415-1421.
9. Swisher SG, Kiertschcr SM, Golub SH, 1 lolmes EC, Roth MD: Pulmonary macrophages suppress the proliferation and cytotoxicity of tumor-infiltrating lymphocytes, Am J RespirCell Mol Biol 1993;8:486-492.
10. Weissler JC, Nicod LP, Toews GB: Pulmonary natural killer cell activity is reduced in patients with bronchogenic carcinoma, Am Rev Respir Dis 1987:135:1353-1357.
11. Muller E, Kolb E: Local responses in primary and secondary human lung cancers, I, Patterns of cellular (eosinophils and macrophages) and extracellular (acid mucopolysaccharide) reactions, Br J Cancer 1979;40:403-409.
12. Norazmi MN, Hohmann AW, Skinner JM, Bradley J: Mononuclear cells in normal colon and colonic carcinoma express the same T cell activation markers, Exp Toxicol Pathol 1992; 44:214-216.
13. Gclb AB, Smoller BR, Warnke RA, Picker LJ: Lymphocytes infiltrating primary cutaneous neoplasms selectively express the cutaneous lymphocyte-associated antigen (CLA), Am J Pathol 1993:142:1556-1564.
14. Marathias KP, Pretïcr FI, Pinto C, Kradin RL: Must human pulmonary infiltrating lymphocytes display the surface immune phenotype and functional response of sensitized Tcells, Am J Respir Cell Mol Biol 1991:5:470-476.
15. Saltini C, Kirby M, Trapnell BC, Tamura N, Crystal RG: Biased accumulation of T lymphocytes with memory type CD45 leucocyte common antigen gene expression on the epithelial surface of the human lung, J Exp Med 1990; 171:1123-1140.
16. Davidson BL, Faust J, Pcssano S, Daniele RP, Rovera G: Differentiation and activation phenotypes of lung T lymphocytes differ from those of circulating T cells, J Clin Invest 1985:76:60-65.
17. Iloi BEA, Hintzen RQ, Van Lier RAW, Alberts C, Out TA, Jansen HM: Soluble and cellular markers of T cell activation in patients with pulmonary sarcoidosis, Am Rev Respir Dis 1993; 148:643-649.
18. Buccheri G, Ferrigno D: Prognostic factors in lung cancer: Tables and comments, Eur Respir J 1994;4:1350-1364.
19. Riemann D, Schwachula A, Hentschel M, Langner J: Demonstration of CDI3/aminopep-tidase N on synovial fluid T cells from patients with different forms of joint effusions, Immunobiology 1993;187:24-35.
20. Sanderink GJ, Artur Y, Siest G: Human aniino-peptidases: A review of the literature, J C'lin Chein Clin Biochem 1988;26:795-807.
21. Amoscato AA, Spiess RR, Sansoni SB, I lerbcr-man RB, Chamber WH: Degradation of enkephalins by rat lymphocyte and purified rat natural killer cell surface aminopcptidases, Brain Behav 1993:7:176-179.
22. Kanayama N, Kajiwara Y, Goto J, EL Maradny F, Maehara K, Andou K, Tereo T: Inactivation of interleukin-8 by aminopcptidase N (CDI3), J LeukocBiol 1995:57:129-134.
23. Delmas B, Gelft J, L'Haridou R, Vogel LK, Sjostrom IT, Noren O, Lundc H: Aminopetidase N is a major receptor for the enteropathogenic corona virus TGEV Nature 1992:357:417-419.
24. Giugni TD, Sodcrberg C, Hamm DJ, Bautista RM, Hedlund KO, Moller E, Zaia JA: Neutralization of human cytomegalovirus by human CD13-specific antibodies, J Infect Dis 1996; 173:1062-1071.
25. Hoshino T, Yamada A, Honda J, Imai Y, Nakao M, lnoue M, Sagawa K, Yokoyama MM, Oizu-mi K, Itoh K: Tissue-specific distribution and age-dependent increase of human CDllb+ T cells, J Immunol 1993;151:2237-2246.
26. McFarland HI, Nahill SR, Maciaszek JW, Welsh RM:C'DI lb (Mac-1): A marker for CD8+cytotoxic Tcell activation and memory in virus infection, J Immunol 1992:149:1326-1333.
27. Sikora K, Alderson T, Ellis J, Philips J, Watson J: Human hybridomas from patients with malignant diseases, Br J Cancer 1983;47:135-139.
28. Goedegebuure PS, Eberlein TJ: The role of CD4+ tumor-infiltrating lymphocytes in human solid tumors, Immunol Res 1995:14:119-131.